Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only-Reference-Cited by-同舟云学术

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Published:2006-08-14 Issue:33-34 Volume:24 Page:5937-5949
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

GIANNINI S,HANON E,MORIS P,VANMECHELEN M,MOREL S,DESSY F,FOURNEAU M,COLAU B,SUZICH J,LOSONKSY G

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application;Coordination Chemistry Reviews;2024-11

2. Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant;Antiviral Research;2024-09

3. Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review;Human Vaccines & Immunotherapeutics;2024-08-28

4. Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate;Antiviral Research;2024-08

5. Therapeutic Role of HPV Vaccination on Benign HPV-induced Epithelial Proliferations in Immunocompetent and Immunocompromised Patients: Case Study and Review of the Literature;Open Forum Infectious Diseases;2024-06-28